Clinical Trials Directory

Trials / Completed

CompletedNCT06745154

Evaluating the Impact of Quitting Using Executive Function Strategy Training (QUEST) on Smoking Cessation in Homeless Young Adult Smokers

QUEST (Quitting Using Executive Function Strategy Training) Research Protocol

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Ohio State University Comprehensive Cancer Center · Academic / Other
Sex
All
Age
18 Years – 24 Years
Healthy volunteers
Not accepted

Summary

This clinical trial evaluates the impact of Quitting Using Executive Function Strategy Training (QUEST) on quitting smoking (cessation) in homeless young adult smokers with an acquired brain injury (ABI). Over 70% of youth and young adults experiencing homelessness (YYEH) smoke tobacco. More than half of YYEH who smoke have made at least one attempt to quit smoking but few use evidence-based methods to increase success. In addition, 9 out of 10 of these have an acquired brain injury which may have a negative impact on successful smoking cessation. QUEST may help homeless young adult smokers with an ABI quit smoking.

Detailed description

PRIMARY OBJECTIVES: I. Gather data needed to build QUEST (Quitting Using Executive function Strategy Training), an intervention to help youth and young adults (YYEH) with executive function dysregulation better 1) access evidence-based cessation; 2) adhere to processes of evidence-based treatment; and 3) address stress to prevent relapse. II. Establish the feasibility of collecting acquired brain injury (ABI) status, and impact data sensitive to change over time (clinical and epigenetic), from YYEH tobacco users in community settings. EXPLORATORY OBJECTIVE: I. Determine if 1) executive functioning 2) mild cognitive impairment and 3) epigenetic age \& other biomarkers of health risk measures are sensitive to difference by ABI status among YYEH past week combustible tobacco users. OUTLINE: Patients receive access to the Ohio Tobacco Quitline, receive nicotine patches, gum, or lozenges for up to 8 weeks. Patients also participate in tobacco cessation counseling sessions for 5 sessions over 8 weeks. Patients additionally undergo cognitive assessment and nasal swab collection on study.

Conditions

Interventions

TypeNameDescription
PROCEDUREBiospecimen CollectionUndergo nasal swab collection
PROCEDURECognitive AssessmentUndergo cognitive assessment
OTHERInterviewAncillary studies
DRUGNicotine ReplacementGiven nicotine patches, gum, or lozenges
BEHAVIORALSmoking Cessation InterventionReceive access to the Ohio Tobacco Quit Line
OTHERSurvey AdministrationAncillary studies
OTHERTobacco Cessation CounselingParticipate in counseling sessions

Timeline

Start date
2023-06-26
Primary completion
2023-08-30
Completion
2023-08-30
First posted
2024-12-20
Last updated
2024-12-20

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06745154. Inclusion in this directory is not an endorsement.